The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor.
about
Redox regulation of FoxO transcription factorsRegulation of protein quality control by UBE4B and LSD1 through p53-mediated transcriptionA human tRNA synthetase is a potent PARP1-activating effector target for resveratrolp38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by berberine.Extracellular signal-regulated kinase signaling-mediated induction and interaction of FOXO3a and p53 contribute to the inhibition of nasopharyngeal carcinoma cell growth by curcuminTranscriptional/epigenetic regulator CBP/p300 in tumorigenesis: structural and functional versatility in target recognition.Threonine 32 (Thr32) of FoxO3 is critical for TGF-β-induced apoptosis via Bim in hepatocarcinoma cells.Extra-Nuclear Signaling Pathway Involved in Progesterone-Induced Up-Regulations of p21cip1 and p27kip1 in Male Rat Aortic Smooth Muscle Cells.Autophagy induction by leptin contributes to suppression of apoptosis in cancer cells and xenograft model: involvement of p53/FoxO3A axisCytosolic Extract of Human Adipose Stem Cells Reverses the Amyloid Beta-Induced Mitochondrial Apoptosis via P53/Foxo3a Pathway.High-Resolution Genomic Profiling of Disseminated Tumor Cells in Prostate CancerFOXO3 signalling links ATM to the p53 apoptotic pathway following DNA damage.Qing'E formula alleviates the aging process in D-galactose-induced aging mice.Genomic profiling defines subtypes of prostate cancer with the potential for therapeutic stratificationCell differentiation versus cell death: extracellular glucose is a key determinant of cell fate following oxidative stress exposure.FOXO transcription factors in cancer development and therapy.The effects of proliferation and DNA damage on hematopoietic stem cell function determine aging.Tumor suppressor FOXO3 regulates ribonucleotide reductase subunit RRM2B and impacts on survival of cancer patients.Genome-wide analysis of p53-regulated transcription in Myc-driven lymphomas.Genome-wide analysis of FOXO3 mediated transcription regulation through RNA polymerase II profiling.5-methoxytryptophan protects MSCs from stress induced premature senescence by upregulating FoxO3a and mTOR.FOXO Signaling Pathways as Therapeutic Targets in Cancer.Restraining FOXO3-dependent transcriptional BMF activation underpins tumour growth and metastasis of E-cadherin-negative breast cancerFOXO3 longevity interactome on chromosome 6p53: key conductor of all anti-acne therapies.Bcl2 deficiency activates FoxO through Akt inactivation and accelerates osteoblast differentiationCharacterization of the direct targets of FOXO transcription factors throughout evolution.FoxO proteins or loss of functional p53 maintain stemness of glioblastoma stem cells and survival after ionizing radiation plus PI3K/mTOR inhibition.A comprehensive and high-resolution genome-wide response of p53 to stress.Transient mitochondrial DNA double strand breaks in mice cause accelerated aging phenotypes in a ROS-dependent but p53/p21-independent manner.Augmentation of oxidative stress-induced apoptosis in MCF7 cells by ascorbate-tamoxifen and/or ascorbate-juglone treatments.Suppression of Activated FOXO Transcription Factors in the Heart Prolongs Survival in a Mouse Model of Laminopathies.Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1.FoxO transcription factors in cancer metabolism.17β-Estradiol Protects Skeletal Myoblasts From Apoptosis Through p53, Bcl-2, and FoxO Families.[Aging and the control of the insulin-FOXO signaling pathway].JNK-dependent downregulation of FoxO1 is required to promote the survival of fibroblast-like synoviocytes in rheumatoid arthritis.Combretastatin A-4 induces p53 mitochondrial-relocalisation independent-apoptosis in non-small lung cancer cells.The longevity SNP rs2802292 uncovered: HSF1 activates stress-dependent expression of FOXO3 through an intronic enhancer.Azelaic acid reduced senescence-like phenotype in photo-irradiated human dermal fibroblasts: possible implication of PPARγ.
P2860
Q26799843-E73D274D-855B-40E6-9BBF-053E4B863376Q27312393-4664E09C-A9CB-4364-A446-7BECB0249789Q28254419-C861F6B2-E82F-461B-B649-713464DC527AQ33581359-52256F13-FE1A-4EDB-A275-71725892C06AQ33836475-2307E979-0F86-477C-A2FD-5BF579CE5FBAQ34035076-47382C22-2569-4DA6-AE90-05A9E0A4EA47Q35034543-B9B22D8A-519C-4852-B1ED-FF06B86942EBQ35561175-20469D47-F1C7-44C5-B591-F161EC80393DQ35740174-826197B7-C6D6-4CDD-9CC2-8DEF110CA5C5Q36238159-ECEE77D0-8CFD-4470-8D74-CE9652E679FBQ36468773-6CC0F480-357D-4DDD-9D7C-9F51B219C314Q36659141-02D649A5-8E53-40EC-9B3D-F9146D9A1AA0Q37001849-52442A88-62BE-44EE-9CE6-7024D773AFC1Q37067529-0C5CDE54-FA45-4D32-8578-D15704745067Q37620707-C9B4BE86-1579-4C46-967B-A2FDA338E9F5Q38674456-B5AE7AA2-455F-4DAF-B9F1-EE749599BC71Q38712466-AD61C825-8029-480A-9579-9383929C970BQ38982791-B6732B07-0BB8-4748-BA3A-CD9AC06F3F12Q39018172-5178B2E3-FEF2-4DC4-982C-88FEA59E6B19Q39206484-0C57A613-942A-4AFE-B6CD-25B3EA3FFCC9Q41326730-F9CF9876-3C24-4315-A475-83C83C8547E7Q41377055-3C6BC038-87A5-4235-B216-7F5713FE6402Q41517649-5BC43803-5696-4AD6-BB10-015A4740F92EQ41628859-AD9F3929-6479-4B5D-832A-3A1C64E88ED5Q41715894-1BC3AD20-F012-414A-A2B0-CEACB1E3E3DAQ41880444-90DCB10F-1F78-4B6C-BB7F-15763FEFFF90Q41961775-E5C54662-61BA-4C22-BEB5-B12A3C04A285Q42317507-64221F06-C7C8-4242-90EE-4E786F3EB278Q42752108-99B1A7B4-7A3E-409B-9219-4495B9BCEF0EQ46451278-AAFB584A-5819-4A59-B5A8-DF347EF4209BQ46640762-5449ECB2-5366-49FB-B223-300254B4B50FQ47215949-7130AC77-90AA-4A20-BE4A-3526C0E671BEQ47262684-9C9FB544-FFAA-4399-AED4-6006B15450BBQ50137602-F50ED6FC-7B19-4B3D-9234-78AEF69A7450Q51726272-DAB0367B-A963-4694-AC61-C7E25AEB0432Q52736080-75EAF700-C5E5-417C-A989-D6192097A801Q53052194-A83D511A-B954-41F4-8E1A-1AFB9ACFE00FQ53085465-1F071949-8AB2-473D-9BF6-D5E824CCC26FQ53686929-2C3F61C4-7295-48ED-A31C-3D7D988EB7DFQ54460976-AF8AF5CC-BCF7-449F-A46A-FBFA9C23C85E
P2860
The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor.
@ast
The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor.
@en
type
label
The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor.
@ast
The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor.
@en
prefLabel
The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor.
@ast
The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor.
@en
P2093
P2860
P356
P1433
P1476
The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor
@en
P2093
D Kenzelmann Broz
L D Attardi
O S Venturelli
P R Oskoui
P2860
P2888
P304
P356
10.1038/ONC.2011.35
P407
P577
2011-03-21T00:00:00Z